Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
29.30
+0.62 (2.16%)
Jan 29, 2026, 1:12 PM EST - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.1 billion as of January 29, 2026. Its market cap has increased by 29.33% in one year.
Market Cap
3.10B
Enterprise Value
2.48B
1-Year Change
29.33%
Ranking
Category
Stock Price
$29.30
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.10B, an increase of 307.58%. That is a compound annual growth rate of 33.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 3.04B | 15.58% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 3.16B |
| Beam Therapeutics | 3.05B |
| IDEAYA Biosciences | 3.02B |
| Erasca | 2.98B |
| Dyne Therapeutics | 2.96B |
| Catalyst Pharmaceuticals | 2.95B |
| Disc Medicine | 2.93B |
| Adaptive Biotechnologies | 2.92B |